Caption Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38,500	Closed	-$285K	–	1953
2024 Q4	$285K	Buy	+38,500	New	+$357K	0.01%	1209
2024 Q3	–	Sell	-30	Closed	-$241	–	1590
2024 Q2	$241	Sell	30 -23,692	-100%	-$254K	﹤0.01%	1113
2024 Q1	$352K	Buy	+23,722	New	+$276K	0.04%	929
2023 Q4	–	Sell	-390,000	Closed	-$2.04M	–	1666
2023 Q3	$1.77M	Buy	390,000 +382,200	+4,900%	+$2.5M	0.23%	614
2023 Q2	$54.9K	Hold	7,800	–	–	0.01%	1003
2023 Q1	$47.7K	Buy	+7,800	New	+$53.8K	0.01%	999
2022 Q4	–	Sell	-5,397	Closed	-$52K	–	1628
2022 Q3	$52K	Sell	5,397 -32,003	-86%	-$369K	0.01%	1382
2022 Q2	$413K	Buy	+37,400	New	+$490K	0.04%	1108
2022 Q1	–	Sell	-70,625	Closed	-$1.09M	–	1836
2021 Q4	$1.35M	Buy	70,625 +41,118	+139%	+$905K	0.08%	932
2021 Q3	$728K	Sell	29,507 -18,493	-39%	-$436K	0.05%	1121
2021 Q2	$1.25M	Buy	+48,000	New	+$1.25M	0.11%	829
2021 Q1	–	Hold	0	–	–	–	1376
2020 Q4	–	Hold	0	–	–	–	1225
2020 Q3	–	Hold	0	–	–	–	1263
2020 Q2	–	Sell	-145,200	Closed	-$4.77M	–	1174
2020 Q1	$4.35M	Buy	145,200 +143,600	+8,975%	+$3.81M	1.42%	119
2019 Q4	$44K	Sell	1,600 -39,200	-96%	-$892K	0.01%	782
2019 Q3	$743K	Sell	40,800 -78,800	-66%	-$1.74M	0.24%	432
2019 Q2	$2.93M	Buy	+119,600	New	+$1.8M	1.02%	189